Moreover, the same study reported that the EP4 agonist ONO 4819CD promoted de novo bone formation in experimental rat models of osteoporosis, induced by ovarectomy and immobilization, respectively (Yoshida et al., 2002). This evidence concerns the gene PTGER4 and osteoporosis.